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1. Introduction
Oxide nanoparticles, as the basic building blocks for 
nanostructure, make the further miniaturization of structures 
and devices possible [1]. How to assemble nanoparticles on 
nanoscale has generated considerable interest in recent 
years [2-10]. Deoxyribonucleic acid (DNA) plays an 
important role in assembling nanoparticles on the nanoscale 
because of its stable physicochemical property, linear and 
semi-rigid molecular structure [11]. The role of DNA in 
assembling metal nanoparticles has been reported [12-19],
but the role of DNA in assembling oxide nanoparticles has 
not been reported as yet. The aim of this paper is to study 
how Zirconia (ZrO2) nanoparticles assemble with the aid of 
DNA. The ZrO2 nanocrystals are important for Bio-medical 
applications such as bioactive coatings on bone implants.
2. Experimental
The ZrO2 ceramic nanoparticles, which were 
synthesized by a hydrothermal reaction, were in a colloidal 
solution. Aqueous solution of ZrOCl2·8H2O was 
neutralized by K2CO3 solution. Then the solution was 
hydrothermally treated at 150 ºC for 1 hour in the Teflon 
lined stainless steel vessel. The detailed hydrothermal 
synthesis is described in a previously reported paper [20].
After the reaction, undesirable K+ and Cl- were removed by 
an ultrafiltration and 5 M of HCl was added to the product 
for dispersion of the nanoparticles in water. The particle
size distribution of the obtained ZrO2 nanoparticle colloidal 
solution was measured by the dynamic light scattering 
(DLS) method, whereas transmission electron microscopy 
(TEM) was used to observe the ZrO2 nanoparticles and 
their assembled nanostructures.
The ZrO2 nanoparticles were assembled by ?-DNA as 
follows. ?-DNA, which was 48502 base-pairs (bp) long, 
was purchased from TaKaRa Biotechnology (Dalian) Co., 
Ltd. The original concentration was 0.3 ?g/?L, and the 
equivalent base pair concentration was 450 ?mol/L. The 
buffer was 10 mmol Tris-HCl-1mmol EDTA, pH=8.0, 
A260/A280=1.8-2.0. The ?-DNA solution (450 ?mol/L bp
concentration) was diluted to a 1 ?mol/L bp concentration 
by adding a 0.0025 mol/L HCl solution to maintain the pH 
of ?-DNA near 3.0. A 900 ?L ZrO2 solution (concentration 
50 ?mol/L) with a HCl solution was prepared to maintain a 
constant pH value of 3.0. Then 900 ?L ZrO2 solution 
(concentration 50 ?mol/L) was added to the 900 ?L
solution of 0.5 ?mol/L bp ?-DNA to make a 1800 ?L
compound solution of 0.25 ?mol/L bp ?-DNA.
3. Results and Discussion
Figure 1(a) and (b) shows a photograph and particle 
size distribution of the obtained transparent ZrO2 colloidal 
solution. The ZrO2 nanoparticle surface contains numerous 
positive charges at a pH value of 3 because the isoelectric 
point of ZrO2 ceramic is around 5-6, and due to the electric 
repulsion force in water, each ZrO2 nanoparticle is assumed 
to be dispersed separately. The average diameter of the 
ZrO2 nanoparticle is about 5 nm, and has a very narrow 
particle distribution (Fig. 1(b)). Fig. 1(c) shows a TEM 
picture of the ZrO2 nanoparticles. Although the primary 
ZrO2 nanoparticles on the TEM grid aggregate after drying 
the colloidal solution, the primary nanoparticles are about 3 
nm, which is consistent with that measured by DLS. Hence, 
it is concluded that the ZrO2 nanoparticles can be dispersed 
perfectly in water under this low pH condition.
Figure 2 shows the TEM picture of the mixed solution 
of ZrO2 nanoparticles and ?-DNA, and indicates that a 
network is formed as the ZrO2 nanoparticles are assembled 
on the DNA strands. In contrast, without DNA, the ZrO2
nanoparticles are aggregated randomly on the TEM grid 
(Fig. 1(c)). However, the ZrO2 nanoparticles are arranged 
in the presence of ?-DNA. This arrangement is likely due to 
the Coulomb interactions between the negatively charged 
DNA and positively charged ZrO2 nanoparticles.
4. Conclusion
The study suggests the DNA plays an important role in 
the assembling of ZrO2 nanoparticles, it provides a 
template for the arraying of nanoparticles. We believe that 
this assembly of metal oxide nanoparticles by DNA will 
yield novel hybrid nano-biomaterials with synergetic 
properties and functions.
Transactions of JWRI is published by Joining and Welding
Research Institute, Osaka University, Ibaraki, Osaka 567-0047,
Japan
† Received on 30 September 2010
* JWRI, Osaka University, Ibaraki, Japan
** Graduate School, Gunma University, Kiryu, Japan
*** Graduate School, Tohoku University, Sendai, Japan
309
Joining of ceramic nanocrystals and bio-molecules towards bio-medical applications
(a)
(b)
10nm
(c)
Fig. 1 (a) Optical image (b) Diameter distribution and (c) 
TEM image of zirconia nanoparticles.
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